Skip to main content

Genetic Diversity

Many animals and plants are losing their genetic diversity, making them more vulnerable


Two-thirds of animal and plant populations are declining in genetic diversity, which makes it harder to adapt to environmental changes, according to research published Wednesday.

Long before a species goes extinct, the population becomes smaller and more fragmented, shrinking the number of potential mates and therefore genetic mixing. This leaves a species more vulnerable to future threats such as disease.

"A surprisingly trend was that we saw genetic diversity declining even among" many species that aren't considered at risk, said co-author Catherine Grueber, a conservation biologist at the University of Sydney.

Researchers examined data for 628 species studied between 1985 and 2019. The greatest losses in genetic variation were seen in birds and mammals.

Findings were published in the journal Nature.

"When a species has different genetic solutions, it's better able to deal with changes," said David Nogués-Bravo at the University of Copenhagen, who was not involved in the study.

If a new disease spreads through a population or climate change alters summer rainfall, some individuals will fare better than others, in part because of their genes. Higher genetic diversity also means there's a greater chance of a species' survival.

Conservation efforts to connect isolated populations—basically expanding the dating pool for a particular species—can help maintain or even restore genetic diversity.

Florida panthers are an endangered species that have steadily lost habitat to freeways and urban sprawl. By the mid-1990s, the remaining big cats in southern Florida showed clear signs of inbreeding—with kinked tails and low sperm counts in males.

Biologists brought eight female panthers from Texas to Florida. Twenty years later, the number of Florida panthers in the wild has grown significantly and genetic diversity increased.

"Isolated populations suffer," said Duke University ecologist Stuart Pimm, who was not part of the research. "The solution is to reconnect them."

Genetic disorders, Inherited diseases, Chromosomal abnormalities, DNA mutations, Hereditary syndromes, Genetic testing, Autosomal dominant, Autosomal recessive, X-linked disorders, Mitochondrial diseases, Genomic medicine, Rare genetic diseases, Precision medicine, Carrier screening, Gene therapy, Genetic counseling, Pediatric genetics, Congenital anomalies, Epigenetic disorders, Molecular diagnostics

#Genetics #GeneticDisorders #DNA #InheritedDiseases #RareDiseases #GenomicMedicine #GeneTherapy #GeneticTesting #MolecularBiology #GeneticCounseling #Mutation #GeneticsResearch #ChromosomalAbnormalities #MedicalGenetics #PediatricGenetics #Epigenetics #PrecisionMedicine #HereditaryDiseases #Genome #Healthcare

Comments

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...